China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
HKD 2.31
(-0.86%)
HKD 2.31
(-0.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 18.12 Billion | 14.3 Billion | 19.05 Billion | 14.8 Billion | 14.32 Billion | 11.25 Billion |
| Cost of Revenue | 8.84 Billion | 7.1 Billion | 7.22 Billion | 5.68 Billion | 5.74 Billion | 5.06 Billion |
| Gross Profit | 9.27 Billion | 7.19 Billion | 11.82 Billion | 9.12 Billion | 8.57 Billion | 6.19 Billion |
| Operating Expenses | 7.84 Billion | 6 Billion | 9.12 Billion | 6.64 Billion | 6.13 Billion | 4.22 Billion |
| Selling, General and Administrative Expenses | 7.44 Billion | 5.54 Billion | 8.55 Billion | 5.58 Billion | 5.1 Billion | 3.41 Billion |
| Research and Development Expenses | 685.63 Million | 611.83 Million | 694.44 Million | 550.47 Million | 463.99 Million | 346.53 Million |
| Other Expenses | -284.93 Million | -152.25 Million | -127.97 Million | 510.21 Million | 564.86 Million | 36.19 Million |
| Cost and Expenses | 16.69 Billion | 13.11 Billion | 16.34 Billion | 12.32 Billion | 11.88 Billion | 9.28 Billion |
| Operating Income | 1.42 Billion | 1.06 Billion | 2.75 Billion | 2.49 Billion | 2.46 Billion | 2.15 Billion |
| Interest Expense | 199.04 Million | 220.69 Million | 222.02 Million | 244.66 Million | 301.04 Million | 292.3 Million |
| Income Tax Expense | -171.53 Million | 119.35 Million | 396.85 Million | 369.44 Million | 381.32 Million | 289.66 Million |
| Earnings before Tax | 1.22 Billion | 840.1 Million | 2.52 Billion | 2.23 Billion | 2.15 Billion | 1.85 Billion |
| Net Income | 1.28 Billion | 764.48 Million | 1.93 Billion | 1.66 Billion | 1.58 Billion | 1.43 Billion |
| Earnings Per Share Basic | 0.26 | 0.15 | 0.38 | 0.33 | 0.32 | 0.30 |
| Earnings Per Share Diluted | 0.26 | 0.15 | 0.38 | 0.33 | 0.32 | 0.30 |
| Weighted Average Shares Outstanding | 5.03 Billion | 5.03 Billion | 5.03 Billion | 5.03 Billion | 5.03 Billion | 4.82 Billion |
| Weighted Average Shares Outstanding (Diluted) | 5.03 Billion | 5.03 Billion | 5.03 Billion | 5.03 Billion | 5.03 Billion | 4.82 Billion |
| Gross Margin | 0.51 | 0.50 | 0.62 | 0.62 | 0.60 | 0.55 |
| EBIT Margin | 0.14 | 0.16 | 0.19 | 0.22 | 0.21 | 0.23 |
| Profit Margin | 0.07 | 0.05 | 0.10 | 0.11 | 0.11 | 0.13 |
| EBITDA | 2.55 Billion | 2.16 Billion | 3.59 Billion | 3.15 Billion | 3.04 Billion | 2.65 Billion |
| Earnings Before Tax Margin | 0.08 | 0.07 | 0.14 | 0.17 | 0.17 | 0.19 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.19 Billion | 4.19 Billion | 4.4 Billion | 18.12 Billion | 4.4 Billion | 4.65 Billion |
| Cost of Revenue | 2.16 Billion | 2.16 Billion | 2.15 Billion | 8.84 Billion | 2.15 Billion | 2.27 Billion |
| Gross Profit | 2.03 Billion | 2.03 Billion | 2.25 Billion | 9.27 Billion | 2.25 Billion | 2.37 Billion |
| Operating Expenses | 1.83 Billion | 1.83 Billion | 1.95 Billion | 7.91 Billion | 1.96 Billion | 1.98 Billion |
| Selling, General and Administrative Expenses | 1.71 Billion | 1.71 Billion | 1.87 Billion | - | 1.87 Billion | 1.84 Billion |
| Research and Development Expenses | 133.96 Million | 133.96 Million | 186 Million | - | 186 Million | 156.8 Million |
| Other Expenses | -6.43 Million | -6.43 Million | -113.47 Million | -432 Thousand | - | - |
| Cost and Expenses | 4 Billion | 4 Billion | 4.1 Billion | 16.76 Billion | 4.12 Billion | 4.26 Billion |
| Operating Income | 192.29 Million | 192.29 Million | 306.61 Million | 1.42 Billion | 282.68 Million | 391.64 Million |
| Interest Expense | - | - | - | 199.04 Million | - | 119.24 Million |
| Income Tax Expense | 42.64 Million | 42.64 Million | 130.69 Million | -171.53 Million | 130.69 Million | 44.92 Million |
| Earnings before Tax | 149.71 Million | 149.71 Million | 258.86 Million | 1.22 Billion | 258.86 Million | 353.4 Million |
| Net Income | 105.48 Million | 105.48 Million | 353.22 Million | 1.28 Billion | 353.22 Million | 289.37 Million |
| Earnings Per Share Basic | 0.02 | 0.02 | 0.07 | - | 0.07 | 0.06 |
| Earnings Per Share Diluted | 0.02 | 0.02 | 0.07 | - | 0.07 | 0.06 |
| Weighted Average Shares Outstanding | 5.03 Billion | 5.03 Billion | 5.03 Billion | 5.03 Billion | 5.03 Billion | 5.03 Billion |
| Weighted Average Shares Outstanding (Diluted) | 5.03 Billion | 5.03 Billion | 5.03 Billion | 5.03 Billion | 5.03 Billion | 5.03 Billion |
| Gross Margin | 0.48 | 0.48 | 0.51 | 0.51 | 0.51 | 0.51 |
| EBIT Margin | 0.11 | 0.11 | 0.12 | - | 0.12 | 0.14 |
| Profit Margin | 0.03 | 0.03 | 0.08 | 0.07 | 0.08 | 0.06 |
| EBITDA | 453.86 Million | 453.86 Million | 546.86 Million | - | 546.86 Million | 663.66 Million |
| Earnings Before Tax Margin | 0.05 | 0.05 | 0.07 | 0.08 | 0.06 | 0.08 |
SING
JLRRF
TMMI
UDAYJEW
JEHLY
217A